Umbralisib Plus Ublituximab Is Superior To Obinutuzumab Plus Chlorambucil In Patients With Treatment-Naive And Relapsed/Refractory Chronic Lymphocytic Leukemia: Results From The Phase 3 Unity-Cll StudyJohn G. Gribben,Wojciech Jurczak,Ryan W. Jacobs,Sebastian Grosicki,Krzysztof Giannopoulos,Tomasz Wrobel,Syed F. Zafar,Jennifer L. Cultrera,Suman Kambhampati,Alexey Danilov,John M. Burke,Jerome Goldschmidt,Douglas F. Beach,Scott F. Huntington,Javier Pinilla Ibarz,Jeff P. Sharman,Tanya Siddiqi,Danielle M. Brander,John M. Pagel,Kathryn S. Kolibaba,Monika Dlugosz-Danecka,Nilanjan Ghosh,Peter Sportelli,Hari P. Miskin,Owen A. O'Connor,Michael S. Weiss,Ian W. FlinnCLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY（2021）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
